Pen Needles Industry Size and Export, Import Analysis 2014-2025 : Grand View Research, Inc.

The global pen needles market is expected to reach a value of USD 4.8 billion by 2025, according to a new report by Grand View Research, Inc. Rising prevalence of diabetes is the primary reason for the significant growth of pen needles market. According to the International Diabetes Federation (IDF), nearly 415 million people were suffering from diabetes in 2015. Such a high prevalence of diabetes across the globe has led to rising demand for pen needles. Patients suffering from diabetes commonly use injectable pen devices, which helps in easy drug delivery.

In addition, obesity is a significant cause of diabetes. Obese people often suffer from type 2 diabetes, which makes them one of the highest revenue contributors of the target market. Thus, people with type 2 diabetes are the common target population for companies manufacturing pen needles.

Rising technological advancements is also expected to drive the market growth. Pen needles allow comfort and easy mode of insulin delivery. These devices are technologically advanced and provide a superior alternative drug delivery method in comparison to syringes and vials. For instance, in 2013, Becton, Dickinson and Company launched BD Ultra-Fine Nano 4mm Pen Needles with EasyFlow Technology, which will enable diabetic patients with easy adherence of insulin therapy regimens.

Full Research Report On pen needles market Analysis:

http://www.grandviewresearch.com/industry-analysis/pen-needles-market

Further Key Findings from the Study Suggest:

·         Standard needles dominated the market in 2015 due to the availability of cost-effective needles as compared to safety needles

·         Safety pen needles are anticipated to showcase lucrative growth over the forecast period due to the continuous technological advancements

·         Amongst the needle lengths, 8mm held the largest share in 2015. This is due to the convenience offered by this needle type on diabetic patients

·         Needle length of 4mm are expected to witness attractive CAGR over the forecast period owing to its short length

·         Insulin therapy accounted for the largest market share in 2015 due to rising awareness regarding self-administration of insulin amongst the diabetic patients

·         Europe dominated the market in 2015 followed by North America owing to high prevalence of diabetes in the European region

·         Asia Pacific region is anticipated to exhibit the highest growth rate over the forecast period owing to the rising awareness levels amongst the diabetic population regarding easy drug delivery

·         Some of the key players include Becton, Dickinson and Company, B. Braun Melsungen AG, Novo Nordisk A/S, Owen Mumford, Ltd., Ypsomed, HTL-STREFA, and TERUMO CORPORATION.

View More Reports Of This Category By Grand View Research At: https://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the pen needles market on the basis of product, needle length, therapy and region:

Pen Needles Product Outlook (Revenue, USD Million; 2014 - 2025)

·         Standard Pen Needles

·         Safety Pen Needles

Pen Needles Length Outlook (Revenue, USD Million; 2014 - 2025)

·         4mm

·         5mm

·         6mm

·         8mm

·         10mm

·         12mm

Pen Needles Therapy Outlook (Revenue, USD Million; 2014 - 2025)

·         Insulin

·         Glucagon-like-Peptide-1 (GLP-1)

·         Growth Hormone

Pen Needles Regional Outlook (Revenue, USD Million; 2014 - 2025)

·         North America

o    U.S.

o    Canada

·         Europe

o    Germany

o    UK

·         Asia Pacific

o    China

o    India

·         Latin America

o    Brazil

o    Mexico

·         MEA

o    South Africa

Access Full Press Release of this Report:
https://www.grandviewresearch.com/press-release/global-pen-needles-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: https://www.grandviewresearch.com/

eHealth Industry Size and Export, Import Analysis 2012-2022 : Grand View Research, Inc.

Global eHealth market is expected to reach USD 308.0 billion by 2022, according to a new report by Grand View Research Inc. The transition of the healthcare industry into digital healthcare system for management and analysis of patient health is expected to be the most vital driver of the market.

Increasing prevalence of chronic diseases, and technological advancements in this field are few impact rendering factors. Rising use of mobile technologies and internet along with increasing adoption for home care by patients is expected to propel market growth over the forecast period.

Furthermore, expanding scope of IT companies pertaining to the development of real-time applications and software catering to the healthcare industry is expected to drive demand over the forecast period. Federal agencies such as the European Coordination Committee of the Radiological, Electromedical and Healthcare IT Industry (COCIR), in order to encourage and popularise eHealth, formulated various policies since 2007. One of these is the eHealth Action Plan, formulated in December 2012, which includes 16 proposed actions to boost eHealth use, focused on increasing research, innovation, interoperability and adoption.

The American Health Information Community (AHIC) was chartered in the U.S. to make recommendations leading to the likely development of eHealth to the Secretary of the U.S. Health Department. Based on these recommendations, efforts are being made to increase awareness levels for currently available mobile applications and wearable remote monitoring devices.

The benefits encouraging higher demand include round the clock care service, wider and faster access to patient information, reduction of administrative and medical errors, self monitoring and management by patients and centralization of entire healthcare industry chain.

Full Research Report On eHealth market Analysis:
https://www.grandviewresearch.com/industry-analysis/e-Health-market

Further key findings from the report suggest:

·         The diagnostics segment of eHealth services market is expected to witness the fastest growth of above 15.0% over the next seven years owing to, the increasing number of patients with at least one chronic condition and rising prevalence of infectious diseases. According to the CDC, more than 50% population of the U.S. accounting for about 117 million people suffer from at least one chronic condition requiring routine monitoring.

·         The mHealth market is expected to be the largest and the fastest growing accounting for a market share of over 24.0% by 2022. According to statistics published by the American Telemedicine Association (ATA), the number of mHealth patents has increased multi-fold from 2000 to 2015 and over 44 million m-Health applications were downloaded in 2015 within North America.

·         North America is expected to dominate the market throughout the forecast period with a revenue share of over 30% by 2022. Presence of technologically updated population base and various current initiatives by the American Health Information Community (AHIC) are expected to be the drivers of this growth.

·         Key players of the market include IBM, McKinsey & Co., Motion Computing Inc., Epocrates Inc., Telecare Corp., Proteus Digital Health and Apple. In June 2014, Apple announced the integration of HealthKit platform into the upcoming iPhone operating system (iOS 8) which will provide a complete health overview of a person such as weight, sleep patterns, heart rates measures, blood pressure and calorie intake.

View More Reports Of This Category By Grand View Research At: https://www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the Global eHealth market on the basis of products, services and region:

eHealth Service Outlook (Revenue, USD Billion, 2012 - 2022)

·         Monitoring Services

o    Vital Sign Monitoring

o    Special Monitoring

o    Adherence Monitoring

o    Accessories

o  Sensors

o  Others

o    Diagnosis Services

o    Healthcare System Strengthening

o    Others

eHealth Type Outlook (Revenue, USD Billion, 2012 - 2022)

·         Electronic Health Record (EHR)

·         E-Prescribing

·         Clinical Decision Support

·         Telemedicine

·         Consumer Health Informatics

·         Health Management

·         mHealth

·         Healthcare Information System

eHealth End-use Outlook (Revenue, USD Billion, 2012 - 2022)

·         Providers

·         Public and Private Insurers

·         Government

·         Healthcare Consumers

eHealth Regional Outlook (Revenue, USD Billion, 2012 - 2022)

·         North America

o    U.S.

o    Canada

·         Europe

o    UK

o    Germany

·         Asia Pacific

o    Japan

o    China

·         Latin America

o    Brazil

·         MEA

o    South Africa

Access Full Press Release of this Report:
https://www.grandviewresearch.com/press-release/global-e-health-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: https://www.grandviewresearch.com/

Structural Biology & Molecular Modeling Techniques Industry Size and Export, Import Analysis 2014-2025 : Grand View Research, Inc.

 The structural biology & molecular modeling techniques market is expected to reach USD 13.1 billion by 2025, according to a new study by Grand View Research, Inc. An unprecedented rise in the adoption of unhealthy lifestyles has led to an upsurge in the prevalence of chronic diseases, such as diabetes and cancer, which is presumed to propel the structural biology & molecular modeling techniques market during the forecast period.

Moreover, increasing drug resistance coupled with the high drug attrition rate is engendering the requirement for extensive R&D activities, which is presumed to boost the adoption of structural biology & molecular modeling techniques in the drug discovery and development process. This is expected to serve as an efficient approach in fast tracking the development of drugs with high potency.

The heightening demand for molecular modeling techniques is predominantly attributable to the significant cost reduction enabled. This is due to the fact that prediction software identifies possible adverse reactions and determines drug efficacy and toxicity in the pre-clinical stages, thereby reducing the probability of drug failure at the later stages. Consequentially, the aforementioned factors serve as prominent reasons responsible for the widened market demand.

Full Research Report On structural biology & molecular modeling techniques market Analysis:
http://www.grandviewresearch.com/industry-analysis/structural-biology-and-molecular-modeling-technique-market

Further key findings from the study suggest:

·         SaaS & standalone modeling held the largest share of the tools segment in 2015 owing to extensive utilization of computer-assisted structuring and modeling techniques in R&D

·         The drug discovery segment is anticipated to grow at a lucrative CAGR owing to continual introduction of software modifications with focus on enhanced drug designing aimed to accelerate the process in identifying novel therapeutic agents

·         In 2015, North America dominated the global structural biology & molecular modeling techniques market owing to the presence of a wide number of established pharmaceutical companies extensively involved in the commercialization of in silico tools to promote their usage

·         Asia Pacific is expected to grow at an exponential CAGR owing to favorable government initiatives supporting research activities and the increasing trend of outsourcing drug development by the developed economies

·         The key participants are employing clinical and research collaborative strategies promoting the adoption of structural prediction software and databases to gain a competitive advantage

View More Reports of This Category by Grand View Research At: https://www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the structural biology & molecular modeling techniques market on the basis of tools, applications, and region:

Tools Outlook (Revenue, USD Million, 2014 - 2025)

·         SaaS & standalone modeling

o    Homology modeling

o    Threading

o    Molecular dynamics

o    Ab Initio

o    Hybrid

o    Others

·         Visualization & analysis

·         Databases

·         Others

Application Outlook (Revenue, USD Million, 2014 - 2025)

·         Drug development

·         Drug discovery

·         Others

Regional Outlook (Revenue, USD Billion, 2014 - 2025)

·         North America

o    U.S.

o    Canada

·         Europe

o    UK

o    Germany

·         Asia Pacific

o    Japan

o    China

o    India

·         Latin America

o    Mexico

o    Brazil

·         MEA

o    South Africa

Access Full Press Release of this Report:
https://www.grandviewresearch.com/press-release/global-structural-biology-molecular-modeling-technique-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: https://www.grandviewresearch.com/